Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Despierre, Evelyn, Vergote, Ignace, Anderson, Ryan, Coens, Corneel, Katsaros, Dionyssios, Hirsch, Fred R, Boeckx, Bram, Varella-Garcia, Marileila, Ferrero, Annamaria, Ray-Coquard, Isabelle
et al (show 6 more authors) (2016) Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy (vol 10, pg 583, 2015). TARGETED ONCOLOGY, 11 (3). p. 429.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Chaplin, Marty ORCID: 0000-0002-7097-8704 and Green, John A
(2021) First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 3 (3). CD010383-.


Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Dwan, Kerry, Boland, Angela ORCID: 0000-0002-5435-8644, Bates, Victoria, Vecchio, Fabio, Dundar, Yenal, Jain, Pooja and Green, John A
(2016) First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer. Cochrane Database of Systematic Reviews, 2016 (5). CD010383-.


Alonso-Alconada, Lorena, Muinelo-Romay, Laura, Madissoo, Kadri, Diaz-Lopez, Antonio, Krakstad, Camilla, Trovik, Jone, Wik, Elisabeth, Hapangama, Dharani ORCID: 0000-0003-0270-0150, Coenegrachts, Lieve, Cano, Amparo
et al (show 22 more authors) (2014) Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Molecular Cancer, 13 (1). 223-.


von Euler, Mikael, Wiman, Klas G, Gabra, Hani, Brenton, James D, Basu, Bristi, Vergote, Ignace, Gourley, Charlie, Smith, Austin, Alfredsson, Jessica, Mohelll, Nina
et al (show 1 more authors) (2015) Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer. .

This list was generated on Wed Feb 7 21:08:46 2024 GMT.